raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:477684

Combined oxidative phosphorylation defect type 26

Synonyms: COXPD26

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Infancy
Status
active

A rare mitochondrial oxidative phosphorylation disorder characterized by a highly variable phenotype which may present as exercise intolerance with prominent exertional dyspnea, progressive muscle weakness, spasticity, and neuropathy, but without cognitive impairment or cardiac involvement, or as global developmental delay, growth retardation, hypotonia, and spasticity. Hypertrophic cardiomyopathy, optic atrophy, seizures, and dysmorphic facial features have also been reported in the more severe phenotype. Serum lactate may be elevated, and muscle biopsy shows myopathic features and variably decreased activity of mitochondrial respiratory chain complexes.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCombined oxidative phosphorylation defect type 26COXPD26
frDéficit combiné de la phosphorylation oxydative type 26= en
deKombinierter Defekt der oxidativen Phosphorylierung Typ 26= en
esDeficiencia combinada de la fosforilación oxidativa tipo 26= en
itDifetto combinato della fosforilazione ossidativa tipo 26
nlGecombineerde oxidatieve fosforylatiedeficiëntie type 26COXPD26 · Gecombineerde oxidatieve fosforyleringdeficiëntie type 26
ptDéfice combinado da fosforilação oxidativa tipo 26
plZłożony defekt fosforylacji oksydacyjnej typu 26= en
csKombinovaný defekt oxidativní fosforylace, typ 26= en
ukКомбінований дефект окисного фосфорилювання, тип 26= en
zh复合氧化磷酸化缺陷26型= en
trKombine oksidatif fosforilasyon defekti tip 26= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616539Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C53.23NTBTattributedvalidated
MONDO0014684Evalidated
UMLSC5567741Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TRMT5Disease-causing germline mutation(s) inAssessedHGNC:23141ENSG0000012681461102314q23.1tRNA methyltransferase 526189817[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated26189817[PMID]_2544623[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_26189817[PMID]_2544623[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card